- Home
- VISN vs LGND Comparison
VISN vs LGND Comparison
Compare VISN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VISN | LGND |
|---|---|---|
| Founded | 1976 | 1987 |
| Country | United States | United States |
| Employees | 4500 | 68 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VISN | LGND |
|---|---|---|
| Price | $10.43 | $225.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $21.00 | ★ $249.71 |
| AVG Volume (30 Days) | ★ 5.1M | 179.8K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.44 | $1.25 |
| Revenue Next Year | $5.91 | $19.41 |
| P/E Ratio | ★ $5.37 | $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.47 | $98.90 |
| 52 Week High | $19.91 | $247.38 |
Technical Indicators
Market Signals| Indicator | VISN | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 17.63 | 54.80 |
| Support Level | N/A | $180.85 |
| Resistance Level | $19.18 | $227.92 |
| Average True Range (ATR) | 0.60 | 10.28 |
| MACD | -0.90 | 0.49 |
| Stochastic Oscillator | 9.36 | 54.83 |
Price Performance
Historical ComparisonAbout VISN Vistance Networks Inc. Common Stock
Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.